Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New targets for antiviral therapy of chronic hepatitis C.

Liver international : official journal of the International Association for the Study of the Liver - 1 Feb 2012

Bühler Sandra, Bartenschlager Ralf

Abstract excerpt

Until recently, chronic hepatitis C caused by persistent infection with the hepatitis C virus (HCV) has been treated with a combination of pegylated interferon-alpha (PEG-IFNα) and ribavirin (RBV). This situation has changed with the development of two drugs targeting the NS3/4A protease, approved for combination therapy with PEG-IFNα/RBV for patients infected with genotype 1 viruses. Moreover, two additional...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Delivery Systems
Share to Genome, Viral
Share to Hepatitis C, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Intracellular Signaling Peptides and Proteins

Share to Protease Inhibitors

Share to RNA-Dependent RNA Polymerase

Share to Viral Nonstructural Proteins

Share to Virus Replication

Source

Identifiers

PMID: 22212566
DOI: 10.1111/j.1478-3231.2011.02701.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New targets for antiviral therapy of chronic hepatitis C.PMID 22212566Read ↗

Hepatitis C Virus Therapies: Current Treatments, Targets and Future PerspectivesSemantic proximity Read ↗

Emerging therapies for hepatitis C virus.Semantic proximity Read ↗

Understanding the hepatitis C virus life cycle paves the way for highly effective therapies.Semantic proximity Read ↗

Current and emerging therapeutic approaches to hepatitis C infection.Semantic proximity Read ↗

Cyclophilin Inhibitors: An Emerging Class of Therapeutics for the Treatment of Chronic Hepatitis C InfectionSemantic proximity Read ↗

New treatments for chronic hepatitis C virus infection.Semantic proximity Read ↗

Recent advances in hepatitis C virus treatment: review of HCV protease inhibitor clinical trials.Semantic proximity Read ↗

Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights.Semantic proximity Read ↗

Direct-Acting Antivirals for Hepatitis C Virus (HCV): The Progress Continues.Semantic proximity Read ↗

A review of current anti-HCV treatment regimens and possible future strategies.Semantic proximity Read ↗

A review on hepatitis C virus: role of viral and host-cellular factors in replication and existing therapeutic strategiesSemantic proximity Read ↗

Hepatitis C virus—biology, host evasion strategies, and promising new therapies on the horizonSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.